New inhibitor which blocks inflammation could also treat sepsis
Scientists have discovered a new OGG1 inhibitor that decreases lung inflammation in mice, which could lead to better treatments for diseases like sepsis and autoimmune disorders. The inhibitor blocks the onset of inflammation associated with oxidative stress, offering a new mechanism for preventing inflammatory conditions.